Ashwagandha KSM-66.
Most researched ashwagandha extract Lowers cortisol, reduces stress and anxiety, improves sleep quality, supports testosterone in men, enhances endurance and recovery.
Reviewed March 2026
- Category
- Herb
- Also filed under
- StressTestosteronePerformance
What Ashwagandha KSM-66 is, and what it does.
- Does it work
- Best-documented ashwagandha. If youre going to take ashwagandha, KSM-66 is the safest bet for consistent, researched results.
- How much to take
- 300-600mg daily. Most studies use 300mg twice daily or 600mg once daily. Higher doses dont necessarily work better.
- Time to feel it
- About eight to nine weeks of daily use.
- The first dose
- Subtle calming effect possible. Most people need 1-2 weeks for noticeable stress reduction.
- With regular use
- Significant stress resilience, better sleep, improved body composition, potential testosterone support (men).
- How well tolerated
- Well tolerated for most people. Rare cases of thyroid changes. May cause sedation in sensitive individuals.
- How it feels
- Calm without drowsiness. Like having a slightly higher stress threshold. Workouts feel more productive.
- The overlooked benefit
- Withanolides are fat soluble, so a meal with some fat in it gets more of them absorbed than water on an empty stomach. Dinner works as well as breakfast.
300 to 600mg a day is where Ashwagandha KSM-66 works.
Source: Chandrasekhar 2012 + Lopresti 2019 meta-analysis
In a 60 day randomised, double-blind, placebo-controlled trial, 60 stressed healthy adults took 240 mg of a standardised ashwagandha extract (Shoden) once daily or placebo. The ashwagandha arm showed a larger fall in Hamilton Anxiety Rating Scale scores (p = .040) and in morning cortisol (p < .001) than placebo, with the DASS-21 change near-significant (p = .096). A separate 8 week randomised, double-blind, placebo-controlled dose-ranging trial enrolled 131 adults with self-reported high stress and analysed 98, measuring reduced Perceived Stress Scale scores at 125, 250 and 500 mg per day of an aqueous root and leaf extract. Two trials on two different extracts, both landing in the same eight to nine week band.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Ashwagandha KSM-66 has emerging evidence. Based on 5+ studies.
- Self-reported everyday stressMeta-analysis
- Cortisol already in the normal range, measured as a markerRandomised trial
- Sleep quality ratingsMeta-analysis
- Testosterone already in the normal range in menRandomised trial
- Endurance and strength output in trainingRandomised trial
- GABA-A receptor modulation as the calming mechanismAnimal study
Questions people ask about Ashwagandha KSM-66.
- When should I take it?
- Morning for energy-related benefits, evening for calming ones. Take with food to reduce any stomach upset.
- How long until I notice something?
- Most people notice something within 2-4 weeks. Full effects usually take 6-8 weeks. Be patient.
- Should I cycle it?
- Good idea. Take 6-8 weeks on, 1-2 weeks off. Adaptogens can lose effectiveness with constant use. Your body adapts to adaptogens (ironic, right?).
- Any drug interactions I should know about?
- Always check with your pharmacist before combining with prescription meds. Herbs can affect how your liver processes drugs, sometimes in surprising ways.
- Fish oil vs. krill oil?
- Both work. Krill is slightly better absorbed (phospholipid form) and has astaxanthin, but costs more. Fish oil at the right dose works just fine for most people.
- How do I avoid fish burps?
- Take it with food. Store in the freezer (seriously, it works). Look for enteric-coated capsules. If it still happens, the oil might be rancid. Give it a sniff.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Ashwagandha's root compounds show GABA-mimetic activity that helps settle an overactive stress response, while l-theanine raises alpha brain-wave activity and shifts the glutamate-to-GABA balance toward calm. The two reach a relaxed but alert state by different routes, which is why they are a long-standing pairing in daytime calm formulas.
Magnesium sits at several calming controls in the nervous system, dampening NMDA glutamate signaling and supporting the parasympathetic side of the stress response, while ashwagandha helps bring an elevated cortisol response back toward its normal daily rhythm. Combining them supports the body's wind-down through complementary calming routes, which is why they often share a sleep or calm formula.
Melatonin is the body's darkness signal and sets the timing of the sleep-wake cycle, while ashwagandha works on a separate front, easing the stress response with GABA-mimetic activity that supports falling asleep. They cover different parts of normal sleep so they are frequently combined, though stacking two calming agents can add to next-morning grogginess.
Both act on the stress axis that governs cortisol, and they are paired because their profiles differ, with ashwagandha leaning calming and rhodiola leaning activating, so together they support a steadier stress response through the day. This reflects settled adaptogen formulation practice rather than a single tested combination.
Withanolides act on GABA-A signalling while glycine works at its own inhibitory receptor and lowers core body temperature at night. The two reach settled sleep onset by different routes.
Phosphatidylserine acts on feedback sensitivity of the hypothalamic pituitary adrenal axis while ashwagandha lowers cortisol output at the adrenal end. Two points on the same normal stress response.
Piperine slows intestinal glucuronidation and some CYP-mediated clearance, raising exposure to lipophilic plant actives. Pepper has been paired with root extracts in practice for the same reason.
Valerenic acid and the withanolides both act as positive modulators at GABA-A sites, so calming effects stack. Useful in an evening formula, worth knowing for daytime dosing.
Ashwagandha raises circulating T4 and T3 within the normal range and iodine is the substrate for making them. Stacking both pushes the same output in one direction.
The deiodinases converting T4 to T3 are selenoproteins, so selenium status governs the step ashwagandha nudges. The effect on normal thyroid hormone levels runs in the same direction.
Caffeine blocks adenosine receptors to raise arousal while withanolides lower sympathetic tone, smoothing the jittery edge without cancelling alertness. Hence its place in stimulant preworkout and focus blends.
Withanolides are lipophilic steroidal lactones with limited water solubility, so a lipid vehicle helps disperse them for uptake.
KSM-66 is one standardised root-only extract of Withania somnifera, distinguished by its aqueous extraction process and declared withanolide percentage. Generic ashwagandha root powder and other branded extracts differ in withanolide content and in whether leaf material is included. Doses studied with one preparation do not transfer cleanly to another.
Bacopa and ashwagandha are combined in Ayurvedic practice and in modern cognitive blends, with bacosides and withanolides studied separately against memory and stress questionnaires. Their reported mechanisms differ, which is the usual argument for stacking them. No trial of the pair together supports an additive effect.
Panax ginseng and ashwagandha are both classed as adaptogens and appear together in fatigue and performance blends. Ginsenosides and withanolides are unrelated chemically and act through different reported routes. The pairing is convention supported by separate single-herb literatures.
Eleutherococcus senticosus is combined with ashwagandha in stress and endurance formulas on the same adaptogen logic. Its eleutherosides are structurally unrelated to withanolides. Nothing has tested the two together in people.
Cordyceps and ashwagandha are routinely combined in endurance and recovery products, each with its own small trial literature on exercise measures. Their proposed mechanisms do not overlap, so the rationale is coverage rather than synergy. Read it as formulation practice.
Hericium erinaceus is paired with ashwagandha in nootropic blends, with hericenones and erinacines studied for nerve growth factor signalling in cell and animal work. That is a different mechanistic story from withanolides and stress axis measures. The combination has not been trialled.
Reishi appears alongside ashwagandha in evening and calm formulas across both East Asian and Ayurvedic-inspired products. Their reported actions differ, with reishi triterpenes and beta-glucans on one side and withanolides on the other. This is convention rather than a measured interaction.
Schisandra lignans are combined with ashwagandha in adaptogen stacks aimed at perceived stress and stamina. Schisandra also interacts with CYP3A4 handling, which is worth naming in any multi-herb product. No pair data exists.
Passionflower is used for evening calm and has GABAergic activity reported in animal and small human work, and ashwagandha extracts are described similarly. Taken together the calming effect can be more than either alone, which matters for anyone driving or operating machinery. Flag the additive direction rather than assuming benefit.
Melissa officinalis has small human trials on tension measures and inhibits GABA transaminase in vitro. Combined with ashwagandha in an evening formula the calming effects stack. The practical point is additive drowsiness, not a demonstrated combination benefit.
Chamomile's apigenin binds benzodiazepine sites in preclinical work and it is a standard evening botanical. Stacked with ashwagandha the sedating direction adds. This is a caution about combined effect rather than an efficacy claim.
Apigenin, the flavone concentrated in chamomile, binds central benzodiazepine sites in animal studies, and ashwagandha withanolides have been described as GABA-A modulators in similar models. Combined, the calming direction is additive. Both descriptions come from preclinical models, not from human receptor occupancy data.
Supplemental GABA is paired with ashwagandha in sleep and calm products, though how much oral GABA crosses into the brain remains contested. Where a person responds to both, the effects add. Name the direction and leave the crossing question open.
5-HTP is a direct serotonin precursor and is used in the same evening category as ashwagandha. Stacking serotonergic and calming ingredients raises the combined sedating effect and is a pairing to be careful with alongside any serotonergic medicine. The caution is the point rather than a benefit claim.
Tryptophan is the dietary precursor for serotonin and then melatonin, and it appears with ashwagandha in evening blends. The two act by different routes and their calming direction adds. As with 5-HTP, combining serotonergic ingredients calls for care.
Ascorbate is concentrated in the adrenal cortex and serves as a cofactor for dopamine beta-hydroxylase in catecholamine synthesis. That is why stress-focused blends often carry vitamin C alongside adaptogen extracts. The cofactor role is established; a combined effect on stress measures is not.
Pantothenate builds coenzyme A, which every steroid hormone synthesis step runs through, and it is a standard component of stress-support blends. Cortisol production depends on that pathway operating normally. Adequacy supports the pathway; extra intake has not been shown to change stress measures.
Pyridoxal-5-phosphate is the cofactor for the decarboxylases that produce serotonin, dopamine and GABA. Any formula built around calm and mood depends on that step running. B6 does not add to withanolide activity; it supports the neurotransmitter machinery in the background.
Zinc is required for testosterone synthesis enzymes and for hundreds of other reactions, and both zinc and ashwagandha appear in male hormonal support blends. The two are studied separately against hormone markers. Hormone concentrations are markers and the pair has not been tested together.
Vitamin D acts through a nuclear receptor present in most tissues, including reproductive tissue, and it appears with ashwagandha in hormonal support products. The rationale is that a hormone-related blend covers a common shortfall. No combination evidence exists for the pair.
Tyrosine is the precursor for dopamine, noradrenaline and adrenaline, the catecholamines that are drawn down under acute stress load. It is paired with ashwagandha in daytime stress formulas on that basis. The precursor relationship is textbook; the combined effect on performance under stress is not established.
Creatine has a large trial literature on strength and lean mass, and ashwagandha extracts have small trials on the same endpoints. Combining them in a training product stacks two separate literatures rather than a demonstrated interaction. A candidate randomised study reported physiological stress measures in team sport athletes taking ashwagandha root extract during a competitive period.
Whey supplies leucine-rich protein for muscle protein synthesis while ashwagandha is included in recovery blends for its stress axis positioning. The two do not interact chemically. This is product design, and the underlying literatures stay separate.
Alpha-GPC supplies choline for acetylcholine synthesis and is combined with ashwagandha in focus and performance products. The mechanisms are unrelated, which is the usual argument for including both. Nothing has been measured for the combination.
Turmeric and ashwagandha are the two most widely used Ayurvedic botanicals in Western supplements and are frequently combined. Both are lipophilic and both benefit from a fat-containing meal. The pairing is traditional and formulational rather than tested as a pair.
Boswellia and ashwagandha appear together in Ayurvedic joint comfort and mobility formulas, each with its own separate trial record. Their reported mechanisms do not overlap. Read the pairing as traditional formulation rather than a measured combination.
Eurycoma longifolia and ashwagandha are the two botanicals most often combined in male hormonal support products, each with small trials reporting hormone markers. Hormone concentrations are markers and the trials are small. The two have not been tested together in a controlled design.
Nothing specific on file for Ashwagandha KSM-66. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Ashwagandha KSM-66 actually does.
KSM-66 is an aqueous, root-only extract of Withania somnifera standardised to a declared percentage of withanolides, which is the class of steroidal lactones taken as its marker compounds.
Withanolide content differs between root and leaf material, and leaf-inclusive extracts carry a different withanolide profile, so extracts are not interchangeable at equal milligram doses.
Withanolides are lipophilic steroidal lactones, so absorption is helped by a fat-containing meal.
Ashwagandha extracts are described as modulating the hypothalamic pituitary adrenal axis, with cortisol used as the measured marker in most human studies; cortisol is a marker and not an outcome in itself.
Getting Ashwagandha KSM-66 from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Across 12 randomised trials in 1,002 adults, ashwagandha supplementation lowered self-reported anxiety scores (standardised mean difference -1.55) and stress scores (-1.75) against placebo, with the authors rating the certainty of the evidence as low.Meta-analysis. Akhgarjand et al., 2022 (Phytotherapy Research). PMID 36017529 ↗
- Pooling five randomised trials in 400 adults, ashwagandha extract produced a small but measurable improvement in overall sleep against placebo (standardised mean difference -0.59), with the effect more prominent at doses of 600 mg a day or more taken for at least eight weeks.Systematic review. Cheah et al., 2021 (PLoS One). PMID 34559859 ↗
- In 57 young men new to resistance training, 300 mg of ashwagandha root extract twice daily for eight weeks raised bench-press one-rep max by about 46 kg versus about 26 kg on placebo, and raised serum testosterone by about 96 ng/dL versus about 18 ng/dL.Randomised trial. Wankhede et al., 2015 (Journal of the International Society of Sports Nutrition). PMID 26609282 ↗
- In 49 healthy athletic adults, KSM-66 ashwagandha root extract raised peak oxygen uptake at maximal exertion by about 5.7 points over 12 weeks compared with about 1.9 on placebo.Randomised trial. Choudhary et al., 2015 (Ayu). PMID 26730141 ↗
- Pooling randomised trials in healthy adults and athletes, ashwagandha supplementation was associated with a modest improvement in maximal oxygen uptake compared with placebo.Meta-analysis. Pérez-Gómez et al., 2020 (Nutrients). PMID 32316411 ↗
- Across human trials of herbal supplements in men, ashwagandha was one of the few with trial evidence of higher circulating testosterone concentrations, while most other herbs reviewed showed no clear change; testosterone is a blood marker rather than an outcome.Systematic review. Smith et al., 2021 (Advances in Nutrition (Bethesda, Md.)). PMID 33150931 ↗
- In adults taking a standardised ashwagandha root extract, the trial reported better scores on cognitive performance tasks and self-reported sleep quality than in the placebo group.Randomised trial. Saxena et al., 2026 (Frontiers in nutrition). PMID 41889719 ↗
- In trained adults doing high-intensity interval training, ashwagandha did not produce a detectable added change in the selected energy metabolism markers compared with placebo, which is a failure to detect a difference rather than evidence that none exists.Randomised trial. Charmas et al., 2025 (Nutrients). PMID 41156498 ↗
- Adults under chronic stress taking ashwagandha root extract reported lower perceived stress scores and showed greater reductions in body weight measures than placebo over the study period.Randomised trial. Pakhale et al., 2025 (Journal of medicine and life). PMID 41635453 ↗
- Healthy men taking ashwagandha root extract reported higher scores on validated sexual wellbeing questionnaires than men on placebo.Randomised trial. Khanna et al., 2026 (Frontiers in reproductive health). PMID 41766918 ↗
- In healthy adults, ashwagandha root extract was well tolerated over the study period, with no differences detected from placebo in liver, kidney, thyroid or haematology laboratory measures.Randomised trial. Movva et al., 2026 (Frontiers in nutrition). PMID 42253745 ↗
- Ashwagandha root extract was reported to keep physiological stress response measures steadier across a competitive period in male and female team sport athletes; the endpoints are physiological markers rather than performance outcomes.Randomised trial. Coope OC et al., 2026 (Nutrients). PMID 41599843 ↗
- In a randomised, double-blind, placebo-controlled design, ashwagandha root extract was compared against placebo on reproductive health measures and tolerability was reported by the authors.Randomised trial. Vani I et al., 2025 (Frontiers in Reproductive Health). PMID 41561822 ↗
- A systematic review of human trials of Withania somnifera reported that most included studies described improvements on tension and stress questionnaires, while noting small sample sizes and variable study quality.Systematic review. Pratte MA et al., 2014 (Journal of Alternative and Complementary Medicine). PMID 25405876 ↗
- A review of standardised Withania somnifera root extract collated reported tolerability findings across the human literature and described the adverse event profile as mostly mild and gastrointestinal.Narrative review. Coope OC et al., 2026 (Pharmaceuticals). PMID 42198398 ↗
- A narrative review summarised immunological and neurological findings attributed to ashwagandha, drawing heavily on preclinical models and describing the human evidence base as still limited in size.Narrative review. Jamnekar PP et al., 2025 (Cureus). PMID 41356880 ↗
- A prospective study reported tolerability observations for ashwagandha root extract during pregnancy; traditional texts and most manufacturers advise against use in pregnancy, so this single report does not settle the question and does not license use.Cohort study. Ajgaonkar A et al., 2026 (Frontiers in Global Women's Health). PMID 41767760 ↗
These are the studies our verdict leans on, chosen from the 2,019 we read for Ashwagandha KSM-66. The full linked list is below.
The studies, linked.
1 source behind our Ashwagandha KSM-66 verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialEffects on Sleep Quality and Bioelectrical Parameters of Cellular Health After Administration of a Plant Protein Supplement Combined With Ashwagandha and RhodiolaClinicalTrials.gov ↗NA · 100 participants · Completed
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.